Details

Autor(en) / Beteiligte

• Zhang, Ting
• Liu, Yong
• Yang, Xianshu
• Martin, Gary E
• Yao, Huifang
• Shang, Jackie
• Bugianesi, Randal M
• Ellsworth, Kenneth P
• Sonatore, Lisa M
• Nizner, Peter
• Sherer, Edward C
• Hill, Susan E
• Knemeyer, Ian W
• Geissler, Wayne M
• Dandliker, Peter J
• Helmy, Roy
• Wood, Harold B

Titel

Definitive Metabolite Identification Coupled with Automated Ligand Identification System (ALIS) Technology: A Novel Approach to Uncover Structure–Activity Relationships and Guide Drug Design in a Factor IXa Inhibitor Program

Ist Teil von

• Journal of medicinal chemistry, 2016-03, Vol.59 (5), p.1818-1829

Ort / Verlag

United States: American Chemical Society

Erscheinungsjahr

2016

Link zum Volltext

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• A potent and selective Factor IXa (FIXa) inhibitor was subjected to a series of liver microsomal incubations, which generated a number of metabolites. Using automated ligand identification system-affinity selection (ALIS-AS) methodology, metabolites in the incubation mixture were prioritized by their binding affinities to the FIXa protein. Microgram quantities of the metabolites of interest were then isolated through microisolation analytical capabilities, and structurally characterized using MicroCryoProbe heteronuclear 2D NMR techniques. The isolated metabolites recovered from the NMR experiments were then submitted directly to an in vitro FIXa enzymatic assay. The order of the metabolites’ binding affinity to the Factor IXa protein from the ALIS assay was completely consistent with the enzymatic assay results. This work showcases an innovative and efficient approach to uncover structure–activity relationships (SARs) and guide drug design via microisolation–structural characterization and ALIS capabilities.